ETAP-Lab - Preclinical Efficacy CRO
Fast-track your pipeline with preclinical excellence. in vitro & in vivo research services since 1991.
Fast-track your pipeline with preclinical excellence. in vitro & in vivo research services since 1991.
ETAP-Lab - Preclinical CRO
Slogan: 30 years of expertise in preclinical pharmacology
Description: ETAP-Lab, founded in 1991, specializes in providing preclinical models and services in the fields of Dermatology, Stroke, and Neurodegenerative Diseases. The company offers a comprehensive portfolio of original in vivo rodent models, including chronic skin inflammation, psoriasis, wound healing, and skin cancer, demonstrating strong expertise in Dermatology research. Moreover, ETAP-Lab has established itself as a leader in preclinical stroke research with its innovative Strok@lliance models. Having obtained ISO9001:v2015 certification for all its preclinical services, the company has become a prominent service provider for top-tier Pharma, Medical device, and Agri-food companies for over 30 years.
Industries: Biotechnology, Health Care
Headquarter: France
Last Investment: N/A
Last Investment Investors: N/A
ETAP-Lab's ability to develop and customize animal models with high translational value to meet specific client needs, from proof-of-concept to early development, positions it as a sought-after partner in the preclinical research space. With its strong track record and expertise, ETAP-Lab presents an intriguing opportunity for potential investors seeking exposure to the biotechnology and healthcare industries.
There is no investment information
No recent news or press coverage available for ETAP-Lab - Preclinical Efficacy CRO.
We care about your data, and we'd love to use cookies make your experience better.
